injectable filler

One treatment procedure primed to propel facial aesthetic procedures forward with unique results and significant science. Irvine, California—February 2, 2012-Syneron Medical Ltd

To help healthcare providers help their overweight and obese patients, the IAPAM has lauched its hCG Physician Medical Weight Management Training . What makes the IAPAM’s hCG Protocol and Training Program the best in the industry is that it’s taught by a faculty who’ve actually done the hCG Protocol themselves! They will educate you on both sides of the program, being the healthcare provider and the patient.  There is no other program like this in North America.  Members also receive phone support after the program is completed, and your patients will be able to join the IAPAM’s patient support groups for long term support. Finally, the IAPAM’s full day hCG training is the only medical weight loss training in North America approved for a special medical malpractice rate for those who have attended and have been certified by the IAPAM

Presented by the IAPAM , the Aesthetic Practice Startup Workshop will prepare you for all the steps needed to add aesthetic medicine to your practice. This session is lead by medical spa industry expert, Jeff Russell, and will certainly help you avoid some of the common pitfalls of the medical spa / aesthetic medicine industry.  If you are going to open a medical spa or incorporate medical aesthetics into your existing practice, you can’t afford to miss this workshop

Most of the advantages that electronic medical records (EMRs) deliver for medically oriented practices also apply to aesthetic surgery practices, according to William Beeson, M.D., a facial plastic surgeon in Carmel, Ind. Key drivers for EMR adoption include legislative requirements, the need to manage billing of third-party payers and the efficiency improvements that EMRs can bring to office workflow, says Dr

The IAPAM’s December 2nd, 2011 session of its comprehensive Physician hCG Training program is the final hCG training session of 2011.  For physicians who want to add hCG for Weight Loss to their practices in preparation for the flood of patients on January 1, 2012, attendance at the December 2nd seminar is the last chance to be educated in the IAPAM’s Exclusive hCG Protocol, and receive all the resources and ongoing support needed to successfully and profitably add hCG for weight loss to a medical practice.    Everyone wants to be healthier and feel good about themselves, yet “adult obesity rates increased in 16 states in the past year and did not decline in any state,” according to F as in Fat: How Obesity Threatens America’s Future 2011.  Equally, in a May 2011 report on the $60.9 Billion Weight Loss Market, Marketdata Enterprises Inc. estimated “75 million dieters” in the US in 2011. To capture a portion of this exploding patient market, the IAPAM’s December 2nd Physician hCG Training program ( http://www.hcgtraining.com ) is the last training session available for physicians who want to add hCG for weight loss to their practices for January 1st of the New Year.

The IAPAM’s hCG Training for Physicians provides physicians with all the education and resources they need to capture a portion of the $2 billion dollar annual market for weight reduction services.  Over 300 physicians attended the IAPAM’s hCG Training in 2011, and are now poised to capture the “2012 New Year’s Resolution” market for loosing weight.  Don’t miss this opportunity to add hCG Medical Weight Loss to your practice.   A June 2011 Risk Rating Report by IBIS World announced that, “the US weight reduction services industry [has a] combined annual revenue of about $2 billion.”  The IAPAM’s hCG Training ( http://www.hcgtraining.com ) is the most comprehensive, one-day training available to help physicians add hCG (human Chorionic Gonadotropin) to their practices and capitalize on this exploding market.    The IAPAM’s hCG Training offers physicians a full-day of intensive education on the clinical best practices of hCG for weight loss, lipotropic injections and Very Low Calorie Diet (VLCD) programs.

California-based pharmaceutical firm Allergan is on the second clinical stage of testing an eyelash lengthener as possible therapy for baldness.   Allergan Chief Executive Office David Pyott said the company expects to see data by the middle of 2012. The medication, Latisse, was approved by the U.S

California-based pharmaceutical firm Allergan is on the second clinical stage of testing an eyelash lengthener as possible therapy for baldness.   Allergan Chief Executive Office David Pyott said the company expects to see data by the middle of 2012. The medication, Latisse, was approved by the U.S.

U.S. drug regulators approved Allergan’s Botox for treating a specific kind of overactive bladder on Wednesday, setting the stage for wider use of the popular wrinkle treatment in those with bladder problems. The U.S.

Baby boomers heading into what used to be called retirement age are providing a 70 million-member strong market for legions of companies, entrepreneurs and cosmetic surgeons eager to capitalize on their “forever young” mindset, whether it’s through wrinkle creams, face-lifts or workout regimens. It adds up to potential bonanza. The market research firm Global Industry Analysts projects that a boomer-fueled consumer base, “seeking to keep the dreaded signs of aging at bay,” will push the U.S.